The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Noncoding regions are the main source of targetable tumor-specific antigens
Abstract
A proteogenomic method identifies potentially actionable tumor-specific antigens and shows that most of them are not coded by classic exons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
Landscape of transcription in human cells
Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., et al. (2012) · Nature · doi:10.1038/nature11233 · Cited by 5,187
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
A fast, lock-free approach for efficient parallel counting of occurrences of k -mers
Marçais, G., & Kingsford, C. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr011 · Cited by 4,661
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
2016 update of the PRIDE database and its related tools
Vizcaíno, J. A., Csordas, A., del-Toro, N., Dianes, J. A., Griss, J., Lavidas, I., Mayer, G., Perez-Riverol, Y., Reisinger, F., Ternent, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1145 · Cited by 3,451
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature · doi:10.1038/nature22991 · Cited by 2,936
Zerbino, D. R., Achuthan, P., Akanni, W., Amode, M. R., Barrell, D., Bhai, J., Billis, K., Cummins, C., Gall, A., Girón, C. G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1098 · Cited by 2,605
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Gubin, M. M., Zhang, X., Schuster, H., Caron, E., Ward, J. P., Noguchi, T., Ivanova, Y., Hundal, J., Arthur, C. D., Krebber, W.-J., et al. (2014) · Nature · doi:10.1038/nature13988 · Cited by 1,974
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
A comparative encyclopedia of DNA elements in the mouse genome
Yue, F., Cheng, Y., Breschi, A., Vierstra, J., Wu, W., Ryba, T., Sandstrom, R., Ma, Z., Davis, C., Pope, B. D., et al. (2014) · Nature · doi:10.1038/nature13992 · Cited by 1,781
CDK4/6 inhibition triggers anti-tumour immunity
Goel, S., DeCristo, M. J., Watt, A. C., BrinJones, H., Sceneay, J., Li, B. B., Khan, N., Ubellacker, J. M., Xie, S., Metzger-Filho, O., et al. (2017) · Nature · doi:10.1038/nature23465 · Cited by 1,513
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Simoni, Y., Becht, E., Fehlings, M., Loh, C. Y., Koo, S.-L., Teng, K. W. W., Yeong, J. P. S., Nahar, R., Zhang, T., Kared, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0130-2 · Cited by 1,370
Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade
Wei, S. C., Levine, J. H., Cogdill, A. P., Zhao, Y., Anang, N.-A. A. S., Andrews, M. C., Sharma, P., Wang, J., Wargo, J. A., Pe’er, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.024 · Cited by 1,302
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Initiative, A. P. C. G., Balachandran, V. P., Łuksza, M., Zhao, J. N., Makarov, V., Moral, J. A., Remark, R., Herbst, B., Askan, G., Bhanot, U., et al. (2017) · Nature · doi:10.1038/nature24462 · Cited by 1,191
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., et al. (2014) · Nature · doi:10.1038/nature14001 · Cited by 1,186 · cited 1×
“To overcome this limitation, a few studies have included mass spectrometry (MS) analyses in their TSA discovery pipeline (17), thereby providing a rigorous molecular definition of several TSAs (18, 19).”
BackgroundGapped sequence alignment using artificial neural networks: application to the MHC class I system
Andreatta, M., & Nielsen, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv639 · Cited by 1,087
Zhang, J., Xin, L., Shan, B., Chen, W., Xie, M., Yuen, D., Zhang, W., Zhang, Z., Lajoie, G. A., & Ma, B. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010587 · Cited by 1,081
Targeting neoantigens to augment antitumour immunity
Yarchoan, M., Johnson, B. A., Lutz, E. R., Laheru, D. A., & Jaffee, E. M. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.154 · Cited by 997
Moon, J. J., Chu, H. H., Pepper, M., McSorley, S. J., Jameson, S. C., Kedl, R. M., & Jenkins, M. K. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.007 · Cited by 976
2016 update of the PRIDE database and its related tools
Vizcaíno, J. A., Csordas, A., del-Toro, N., Dianes, J. A., Griss, J., Lavidas, I., Mayer, G., Perez-Riverol, Y., Reisinger, F., Ternent, T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw880 · Cited by 807
Proteogenomics: concepts, applications and computational strategies
Nesvizhskii, A. I. (2014) · Nature Methods · doi:10.1038/nmeth.3144 · Cited by 770
Bassani-Sternberg, M., Bräunlein, E., Klar, R., Engleitner, T., Sinitcyn, P., Audehm, S., Straub, M., Weber, J., Slotta-Huspenina, J., Specht, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms13404 · Cited by 693
ENCODE data at the ENCODE portal
Sloan, C. A., Chan, E. T., Davidson, J. M., Malladi, V. S., Strattan, J. S., Hitz, B. C., Gabdank, I., Narayanan, A. K., Ho, M., Lee, B. T., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1160 · Cited by 544
Mlecnik, B., Bindea, G., Kirilovsky, A., Angell, H. K., Obenauf, A. C., Tosolini, M., Church, S. E., Maby, P., Vasaturo, A., Angelova, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6352 · Cited by 472
Role of non-coding sequence variants in cancer
Khurana, E., Fu, Y., Chakravarty, D., Demichelis, F., Rubin, M. A., & Gerstein, M. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2015.17 · Cited by 468
Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J., & Mann, M. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.042812 · Cited by 426
Huang, A. Y., Gulden, P. H., Woods, A. S., Thomas, M. C., Tong, C. D., Wang, W., Engelhard, V. H., Pasternack, G., Cotter, R., Hunt, D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9730 · Cited by 388
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
Castle, J. C., Loewer, M., Boegel, S., de Graaf, J., Bender, C., Tadmor, A. D., Boisguerin, V., Bukur, T., Sorn, P., Paret, C., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-190 · Cited by 384
MHC-I Genotype Restricts the Oncogenic Mutational Landscape
Marty, R., Kaabinejadian, S., Rossell, D., Slifker, M. J., van de Haar, J., Engin, H. B., de Prisco, N., Ideker, T., Hildebrand, W. H., Font-Burgada, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.050 · Cited by 352
The Role of Naive T Cell Precursor Frequency and Recruitment in Dictating Immune Response Magnitude
Jenkins, M. K., & Moon, J. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102661 · Cited by 309
Chen, W., Antón, L. C., Bennink, J. R., & Yewdell, J. W. (2000) · Immunity · doi:10.1016/s1074-7613(00)80161-2 · Cited by 309
Immune responses to endogenous retroelements: taking the bad with the good
Kassiotis, G., & Stoye, J. P. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.27 · Cited by 274
Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes
Gee, M. H., Han, A., Lofgren, S. M., Beausang, J. F., Mendoza, J. L., Birnbaum, M. E., Bethune, M. T., Fischer, S., Yang, X., Gomez-Eerland, R., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.043 · Cited by 272
Laumont, C. M., Daouda, T., Laverdure, J.-P., Bonneil, É., Caron-Lizotte, O., Hardy, M.-P., Granados, D. P., Durette, C., Lemieux, S., Thibault, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms10238 · Cited by 269
Self-citationAutoimmunity against a defective ribosomal insulin gene product in type 1 diabetes
Kracht, M. J. L., van Lummel, M., Nikolic, T., Joosten, A. M., Laban, S., van der Slik, A. R., van Veelen, P. A., Carlotti, F., de Koning, E. J. P., Hoeben, R. C., et al. (2017) · Nature Medicine · doi:10.1038/nm.4289 · Cited by 234
Database of T cell-defined human tumor antigens: the 2013 update.
Vigneron, N., Stroobant, V., den Eynde, B. J. V., & van der Bruggen, P. (2013) · Europe PMC (PubMed Central) · Cited by 226
Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses
Welters, M. J., van der Sluis, T. C., van Meir, H., Loof, N. M., van Ham, V. J., van Duikeren, S., Santegoets, S. J., Arens, R., de Kam, M. L., Cohen, A. F., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad8307 · Cited by 216
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry*
Caron, E., Kowalewski, D., Chiek Koh, C., Sturm, T., Schuster, H., & Aebersold, R. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o115.052431 · Cited by 213
Hung, A. C. F. (1996) · Medical Entomology and Zoology · Cited by 206
MHC class I–associated peptides derive from selective regions of the human genome
Pearson, H., Daouda, T., Granados, D. P., Durette, C., Bonneil, E., Courcelles, M., Rodenbrock, A., Laverdure, J.-P., Côté, C., Mader, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88590 · Cited by 196
Self-citationGeneration of diversity in thymic epithelial cells
Takahama, Y., Ohigashi, I., Baik, S., & Anderson, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.12 · Cited by 187
Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D.-C., & Perreault, C. (2001) · Nature Medicine · doi:10.1038/89907 · Cited by 178
Self-citationThe MHC class I peptide repertoire is molded by the transcriptome
Fortier, M.-H., Caron, E., Hardy, M.-P., Voisin, G., Lemieux, S., Perreault, C., & Thibault, P. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071985 · Cited by 171
Self-citationPredicting Antigen Presentation—What Could We Learn From a Million Peptides?
Gfeller, D., & Bassani-Sternberg, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01716 · Cited by 170
Mass spectrometry-based antigen discovery for cancer immunotherapy
Bassani‐Sternberg, M., & Coukos, G. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.04.005 · Cited by 148
Onco-proteogenomics: cancer proteomics joins forces with genomics
Alfaro, J. A., Sinha, A., Kislinger, T., & Boutros, P. C. (2014) · Nature Methods · doi:10.1038/nmeth.3138 · Cited by 145
The problem with neoantigen prediction
(2017) · Nature Biotechnology · doi:10.1038/nbt.3800 · Cited by 145
Shao, W., Pedrioli, P. G. A., Wolski, W., Scurtescu, C., Schmid, E., Vizcaíno, J. A., Courcelles, M., Schuster, H., Kowalewski, D. J., Marino, F., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx664 · Cited by 139
Self-citationThe MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation
Caron, É., Vincent, K., Fortier, M., Laverdure, J., Bramoullé, A., Hardy, M., Voisin, G., Roux, P. P., Lemieux, S., Thibault, P., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.68 · Cited by 136
Self-citationAn Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors
Lu, Y., Zheng, Z., Robbins, P. F., Tran, E., Prickett, T. D., Gartner, J. J., Li, Y. F., Ray, S., Franco, Z., Bliskovsky, V. V., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.018 · Cited by 108
Mass spectrometrists should search only for peptides they care about
Noble, W. S. (2015) · Nature Methods · doi:10.1038/nmeth.3450 · Cited by 93
Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy
Laumont, C. M., & Perreault, C. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2628-4 · Cited by 82
Self-citationYoung, Proliferative Thymic Epithelial Cells Engraft and Function in Aging Thymuses
Kim, M., Miller, C. M., Shadrach, J. L., Wagers, A. J., & Serwold, T. F. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403158 · Cited by 79
Lanoix, J., Durette, C., Courcelles, M., Cossette, É., Comtois‐Marotte, S., Hardy, M., Côté, C., Perreault, C., & Thibault, P. (2018) · PROTEOMICS · doi:10.1002/pmic.201700251 · Cited by 79
Self-citationThe nature of self for T cells — a systems-level perspective
Granados, D. P., Laumont, C. M., Thibault, P., & Perreault, C. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.012 · Cited by 75
Self-citationProbst, P., Kopp, J., Oxenius, A., Colombo, M. P., Ritz, D., Fugmann, T., & Neri, D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2946 · Cited by 73
Bereman, M. S., Beri, J., Sharma, V., Nathe, C., Eckels, J., MacLean, B., & MacCoss, M. J. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00744 · Cited by 68
Rosenberg, S. A., Tong-On, P., Li, Y., Riley, J. P., El‐Gamil, M., Parkhurst, M. R., & Robbins, P. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2402 · Cited by 66
Characterizing neoantigens for personalized cancer immunotherapy
Capietto, A.-H., Jhunjhunwala, S., & Delamarre, L. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.04.007 · Cited by 65
Hu, Z., Anandappa, A. J., Sun, J., Kim, J., Leet, D., Bozym, D. J., Chen, C., Williams, L., Shukla, S. A., Zhang, W., et al. (2018) · Blood · doi:10.1182/blood-2018-04-843763 · Cited by 65
Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era
Martin, S. D., Coukos, G., Holt, R. A., & Nelson, B. H. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv382 · Cited by 57
Vita, R., Overton, J. A., Mungall, C., Sette, A., & Peters, B. (2018) · Database · doi:10.1093/database/bax105 · Cited by 44
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Legoux, F. P., & Moon, J. J. (2012) · Journal of Visualized Experiments · doi:10.3791/4420 · Cited by 28
Isolation of Myeloid Dendritic Cells and Epithelial Cells from Human Thymus
Stoeckle, C., Rota, I. A., Tolosa, E., Haller, C., Melms, A., & Adamopoulou, E. (2013) · Journal of Visualized Experiments · doi:10.3791/50951 · Cited by 26
Identification of Immunogenic Epitopes by MS/MS
Marco, M. D., Peper-Gabriel, J. K., & Rammensee, H. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000252 · Cited by 26
pyGeno: A Python package for precision medicine and proteogenomics
Daouda, T., Perreault, C., & Lemieux, S. (2016) · F1000Research · doi:10.12688/f1000research.8251.1 · Cited by 19
Self-citationRejection of Leukemic Cells Requires Antigen-Specific T Cells with High Functional Avidity
Vincent, K., Hardy, M., Trofimov, A., Laumont, C. M., Sriranganadane, D., Hadj-Mimoune, S., Fourati, I. S., Soudeyns, H., Thibault, P., & Perreault, C. (2013) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2013.10.020 · Cited by 10
Self-citationIsolation of Myeloid Dendritic Cells and Epithelial Cells from Human Thymus
Stoeckle, C., Rota, I. A., Tolosa, E., Haller, C., Melms, A., & Adamopoulou, E. (2013) · Journal of Visualized Experiments · doi:10.3791/50951-v · Cited by 9
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Roles and mechanisms of alternative splicing in cancer — implications for care
Bonnal, S. C., López-Oreja, I., & Valcárcel, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0350-x · Cited by 731
Neoantigen vaccine: an emerging tumor immunotherapy
Peng, M., Mo, Y., Wang, Y., Wu, P., Zhang, Y., Xiong, F., Guo, C., Wu, X., Li, Y., Li, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1055-6 · Cited by 700
Turning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
Identification of neoantigens for individualized therapeutic cancer vaccines
Lang, F., Schrörs, B., Löwer, M., Türeci, Ö., & Sahin, U. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00387-y · Cited by 534
Metadata
- Authors
- Laumont, C. M., Vincent, K., Hesnard, L., Audemard, É., Bonneil, É., Laverdure, J.-P., Gendron, P., Courcelles, M., Hardy, M.-P., Côté, C., Durette, C., St-Pierre, C., Benhammadi, M., Lanoix, J., Vobecky, S., Haddad, E., Lemieux, S., Thibault, P., & Perreault, C.
- Venue
- Science Translational Medicine
- Published
- 2018-12-05
- Volume
- 10
- Issue
- 470
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2903083041
- Cited by
- 535
- References
- 71
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.